Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

ECC 2015

Videos
News
European Commission: Actions to tackle cancer
Dr Vytenis Andriukaitis - EU Commissioner for Health and Food Safety
European Commission: Actions to tackle cancer ( Dr Vytenis Andriukaitis - EU Commissioner for Health and Food Safety )
29 Oct 2015
How do disparities affect cancer patients across Europe?
Prof Mark Lawler - Chair of the EAPM Research Subgroup
How do disparities affect cancer patients across Europe? ( Prof Mark Lawler - Chair of the EAPM Research Subgroup )
21 Oct 2015
The importance of significant genetic variations between breast cancers
Dr Lucy Yates - Wellcome Trust Sanger Institute and the University of Cambridge...
The importance of significant genetic variations between breast cancers ( Dr Lucy Yates - Wellcome Trust Sanger Institute and the University of Cambridge, Cambridge, UK )
8 Oct 2015
What is the AMORIS study?
Prof Mieke van Hemelrijck - Kings College London, London, UK
What is the AMORIS study? ( Prof Mieke van Hemelrijck - Kings College London, London, UK )
7 Oct 2015
What is the European cancer accreditation programme?
Anke Wind, M.P.H - Netherlands Cancer Institute, Amsterdam, Netherlands
What is the European cancer accreditation programme? ( Anke Wind, M.P.H - Netherlands Cancer Institute, Amsterdam, Netherlands )
7 Oct 2015
What are the obstacles in cancer prevention?
Prof Jack Cuzick - Queen Mary University of London, London, UK
What are the obstacles in cancer prevention? ( Prof Jack Cuzick - Queen Mary University of London, London, UK )
7 Oct 2015
Epigenetics in cancer genesis
Dr Manel Esteller – Instituto de Investigación Biomédica de Bellvitge...
Epigenetics in cancer genesis ( Dr Manel Esteller – Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain )
7 Oct 2015
Results of 5 year phase III randomised trial treating localised prostate cancer
Prof David Dearnaley - Institute of Cancer Research, London, UK
Results of 5 year phase III randomised trial treating localised prostate cancer ( Prof David Dearnaley - Institute of Cancer Research, London, UK )
7 Oct 2015
How has surgery developed over the last decade?
Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy
How has surgery developed over the last decade? ( Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy )
6 Oct 2015
Is lung cancer screening ready for implementation in Europe?
Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy
Is lung cancer screening ready for implementation in Europe? ( Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy )
6 Oct 2015
ECC 2015: Editor's highlights
Prof Gordon McVie - ecancer Managing Editor
ECC 2015: Editor's highlights ( Prof Gordon McVie - ecancer Managing Editor )
5 Oct 2015
Surgery in synchronous oligometastatic disease
Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden
Surgery in synchronous oligometastatic disease ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )
2 Oct 2015
Are we providing adequate surgical care?
Prof Riccardo Audisio - President of the European Society for Surgical Oncology
Are we providing adequate surgical care? ( Prof Riccardo Audisio - President of the European Society for Surgical Oncology )
2 Oct 2015
European Pharma companies to disclose health professional payments
Andrew Powrie-Smith - European Federation of Pharmaceutical Industries and...
European Pharma companies to disclose health professional payments ( Andrew Powrie-Smith - European Federation of Pharmaceutical Industries and Associations, Brussels, Belgium )
2 Oct 2015
Diagnosis while pregnant should not lead to treatment delay or pregnancy...
Prof Frederic Amant - Katholieke Universiteit Leuven, Leuven, Belgium
Diagnosis while pregnant should not lead to treatment delay or pregnancy termination ( Prof Frederic Amant - Katholieke Universiteit Leuven, Leuven, Belgium )
2 Oct 2015
First ‘targeted’ treatment for small cell lung cancer shows promise
Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA
First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA )
2 Oct 2015
DDFMISO trial confirms significant negative prognostic value of tumour hypoxia
Prof Michael Baumann - University Hospital Carl Gustav Carus, Dresden, Germany
DDFMISO trial confirms significant negative prognostic value of tumour hypoxia ( Prof Michael Baumann - University Hospital Carl Gustav Carus, Dresden, Germany )
2 Oct 2015
Results of a placebo­ controlled study of tasquinimod in men with metastatic...
Dr Michael A. Carducci - Johns Hopkins University, Baltimore, USA
Results of a placebo­ controlled study of tasquinimod in men with metastatic castrate resistant prostate cancer ( Dr Michael A. Carducci - Johns Hopkins University, Baltimore, USA )
2 Oct 2015
Brain metastases genomic analysis could reveal new targets for treatment
Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA
Brain metastases genomic analysis could reveal new targets for treatment ( Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA )
2 Oct 2015
'Survivor passport' for survivors of childhood leukaemia
Prof Martin Schrappe - University Medical Center Schleswig-Holstein, Kiel...
'Survivor passport' for survivors of childhood leukaemia ( Prof Martin Schrappe - University Medical Center Schleswig-Holstein, Kiel, Germany )
1 Oct 2015
Hodgkin lymphoma incidence in young affected by social deprivation, gender
Dr Richard McNally - Newcastle University, Newcastle, UK
Hodgkin lymphoma incidence in young affected by social deprivation, gender ( Dr Richard McNally - Newcastle University, Newcastle, UK )
1 Oct 2015
Progression of childhood cancers in Europe
Prof Gilles Vassal - University Paris-Sud, Orsay, France
Progression of childhood cancers in Europe ( Prof Gilles Vassal - University Paris-Sud, Orsay, France )
1 Oct 2015
HPV vaccines for cancer prevention
Prof Jack Cuzick - Queen Mary University of London, London, UK
HPV vaccines for cancer prevention ( Prof Jack Cuzick - Queen Mary University of London, London, UK )
1 Oct 2015
Is it possible to develop cancer drugs at a lower cost?
Prof Andrew Hill - University of Liverpool, Liverpool, UK
Is it possible to develop cancer drugs at a lower cost? ( Prof Andrew Hill - University of Liverpool, Liverpool, UK )
1 Oct 2015
Examining NSCLC responses to durvalumab monotherapy
Brandon Higgs - MedImmune, Gaithersburg, USA
Examining NSCLC responses to durvalumab monotherapy ( Brandon Higgs - MedImmune, Gaithersburg, USA )
1 Oct 2015
Expanding access to crizotinib using a biomarker-driven approach
Prof Gilles Vassal - University Paris-Sud, Orsay, France
Expanding access to crizotinib using a biomarker-driven approach ( Prof Gilles Vassal - University Paris-Sud, Orsay, France )
1 Oct 2015
ECC 2015 scientific highlights
Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden
ECC 2015 scientific highlights ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )
30 Sep 2015
Time between melanoma excision and sentinel node biopsy does not affect survival
Charlotte Oude Ophuis - Erasmus MC Cancer Institute, Rotterdam, Netherlands
Time between melanoma excision and sentinel node biopsy does not affect survival ( Charlotte Oude Ophuis - Erasmus MC Cancer Institute, Rotterdam, Netherlands )
30 Sep 2015
Atezolizumab limits disease progression for metastatic urothelial bladder cancer
Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
Atezolizumab limits disease progression for metastatic urothelial bladder cancer ( Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
30 Sep 2015
Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC
Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France
Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC ( Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France )
30 Sep 2015
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise
Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA )
28 Sep 2015
A cancer diagnosis while pregnant should not lead to treatment delay or...
Prof Frédéric Amant - Katholieke Universiteit Leuven, Leuven, Belgium
A cancer diagnosis while pregnant should not lead to treatment delay or pregnancy termination ( Prof Frédéric Amant - Katholieke Universiteit Leuven, Leuven, Belgium )
28 Sep 2015
Social deprivation and gender affects incidence of Hodgkin lymphoma in children...
Dr Richard McNally - Newcastle University, Newcastle, UK
Social deprivation and gender affects incidence of Hodgkin lymphoma in children and young adults ( Dr Richard McNally - Newcastle University, Newcastle, UK )
28 Sep 2015
Multi-peptide vaccine for kidney cancer fails to improve survival
Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA
Multi-peptide vaccine for kidney cancer fails to improve survival ( Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA )
28 Sep 2015
Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC
Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium
Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )
28 Sep 2015
Latest in lung cancer from ECC 2015
Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Latest in lung cancer from ECC 2015 ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
28 Sep 2015
Survival in all gastrointestinal cancers improved by aspirin post diagnosis
Ms Martine Frouws - Leiden University Medical Center, Leiden, The Netherlands
Survival in all gastrointestinal cancers improved by aspirin post diagnosis ( Ms Martine Frouws - Leiden University Medical Center, Leiden, The Netherlands )
28 Sep 2015
Watchful waiting versus neck dissection in patients with head and neck cancers
Prof Hisham Mehanna - University of Birmingham, Birmingham, UK
Watchful waiting versus neck dissection in patients with head and neck cancers ( Prof Hisham Mehanna - University of Birmingham, Birmingham, UK )
28 Sep 2015
How can we improve current treatments for osteosarcomas?
Prof Stefan Bielack - Klinikum Stuttgart, Stuttgart, Germany
How can we improve current treatments for osteosarcomas? ( Prof Stefan Bielack - Klinikum Stuttgart, Stuttgart, Germany )
28 Sep 2015
Over three-quarters of people with cancer worldwide have no access to safe...
Prof Richard Sullivan - King's College London, London, UK
Over three-quarters of people with cancer worldwide have no access to safe surgery ( Prof Richard Sullivan - King's College London, London, UK )
28 Sep 2015
Majority of cancer patients worldwide have no access to safe surgery
Prof Richard Sullivan - King's College London, London, UK
Majority of cancer patients worldwide have no access to safe surgery ( Prof Richard Sullivan - King's College London, London, UK )
28 Sep 2015
Add panitumumab or bevacizumab to improve first-line metastatic colorectal...
Dr Fernardo Rivera - Hospital Universitario Marques de Valdecilla, Santander...
Add panitumumab or bevacizumab to improve first-line metastatic colorectal cancer therapy? ( Dr Fernardo Rivera - Hospital Universitario Marques de Valdecilla, Santander, Spain )
28 Sep 2015
Regional lymph node irradiation in early breast cancer
Prof Philip Poortmans - Radboud University Medical Center, Nijmegen, The...
Regional lymph node irradiation in early breast cancer ( Prof Philip Poortmans - Radboud University Medical Center, Nijmegen, The Netherlands )
28 Sep 2015
Hormonal suppression prevents ovarian failure, preserves fertility in women...
Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy
Hormonal suppression prevents ovarian failure, preserves fertility in women with breast cancer ( Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy )
28 Sep 2015
Post diagnosis aspirin improves survival in all gastrointestinal cancers
Ms Martine Frouws - Leiden University Medical Center, Leiden, Netherlands
Post diagnosis aspirin improves survival in all gastrointestinal cancers ( Ms Martine Frouws - Leiden University Medical Center, Leiden, Netherlands )
28 Sep 2015
Preventing ovarian failure and preserve fertility in women with breast cancer...
Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy
Preventing ovarian failure and preserve fertility in women with breast cancer with hormonal therapy ( Dr Matteo Lambertini - Ospedale San Martino, Genoa, Italy )
28 Sep 2015
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer:...
Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review ( Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK )
28 Sep 2015
PD-L2 expression and its relevance to anti-PD-1 therapy in cancer
Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA
PD-L2 expression and its relevance to anti-PD-1 therapy in cancer ( Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA )
28 Sep 2015
Dabrafenib plus trametinib improves melanoma patients’ survival
Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France
Dabrafenib plus trametinib improves melanoma patients’ survival ( Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France )
28 Sep 2015
COMBI-V: Melanoma survival improved by targeted drug combination
Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France
COMBI-V: Melanoma survival improved by targeted drug combination ( Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France )
28 Sep 2015
Economics of radiotherapy and radiotherapy boost for high grade invasive breast...
Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands
Economics of radiotherapy and radiotherapy boost for high grade invasive breast cancer ( Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands )
28 Sep 2015
Prostate highlights from ECC 2015
Prof Noel Clarke and Dr Bertrand Tombal
Prostate highlights from ECC 2015 ( Prof Noel Clarke and Dr Bertrand Tombal )
27 Sep 2015
EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors...
Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland
EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors on long-term local control ( Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland )
27 Sep 2015
Cabozantinib improves advanced kidney cancer survival: METEOR trial results
Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Cabozantinib improves advanced kidney cancer survival: METEOR trial results ( Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
27 Sep 2015
Melanoma immunotherapy latest and TVEC plus pembrolizumab
Dr Georgina Long - University of Sydney, Sydney, Australia
Melanoma immunotherapy latest and TVEC plus pembrolizumab ( Dr Georgina Long - University of Sydney, Sydney, Australia )
27 Sep 2015
Genetic screening of brain metastases could reveal new targets for treatment
Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA
Genetic screening of brain metastases could reveal new targets for treatment ( Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA )
27 Sep 2015
NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs
Prof Philippe Ruszniewski - Paris Diderot University, Paris, France
NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs ( Prof Philippe Ruszniewski - Paris Diderot University, Paris, France )
27 Sep 2015
RADIANT-4: Results of international trial show promise in the treatment of...
Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA
RADIANT-4: Results of international trial show promise in the treatment of neuroendocrine tumours ( Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA )
27 Sep 2015
Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results
Prof Philippe Ruszniewski - Paris Diderot University, Paris, France
Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results ( Prof Philippe Ruszniewski - Paris Diderot University, Paris, France )
27 Sep 2015
Comment: EUROCARE-5, large blood cancer survival differences throughout Europe
Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Comment: EUROCARE-5, large blood cancer survival differences throughout Europe ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
27 Sep 2015
Comment: New immunotherapy options for kidney cancer
Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Comment: New immunotherapy options for kidney cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
26 Sep 2015
Tailoring treatment strategies in prostate cancer: expert insight
Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu
Tailoring treatment strategies in prostate cancer: expert insight ( Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu )
26 Sep 2015
Tackling global radiotherapy shortfall could save millions of lives and boost...
Prof Rifat Atun - Harvard University, Boston, USA
Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries ( Prof Rifat Atun - Harvard University, Boston, USA )
26 Sep 2015
Large variations found in survival from blood cancers between European countries
Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy
Large variations found in survival from blood cancers between European countries ( Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy )
26 Sep 2015
CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated...
Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA
CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )
26 Sep 2015
Everolimus for non-functional neuroendocrine tumours
Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA
Everolimus for non-functional neuroendocrine tumours ( Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA )
26 Sep 2015
EUROCARE-5 results show large variations in survival from blood cancers between...
Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy
EUROCARE-5 results show large variations in survival from blood cancers between European countries ( Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy )
26 Sep 2015
Nivolumab improves overall survival for advanced kidney cancer
Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA
Nivolumab improves overall survival for advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )
26 Sep 2015
METEOR trial results: Cabozantinib improves advanced kidney cancer survival
Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
METEOR trial results: Cabozantinib improves advanced kidney cancer survival ( Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
26 Sep 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation